image
Healthcare - Biotechnology - NASDAQ - US
$ 37.25
-0.268 %
$ 5.85 B
Market Cap
248.33
P/E
BALANCE SHEET
578 M ASSETS
75.28%
355 M LIABILITIES
110.15%
222 M EQUITY
38.54%
BALANCE SHEET DECOMPOSITION
Balance Sheet TG Therapeutics, Inc.
image
Current Assets 566 M
Cash & Short-Term Investments 311 M
Receivables 129 M
Other Current Assets 126 M
Non-Current Assets 11.3 M
Long-Term Investments 808 K
PP&E 7.15 M
Other Non-Current Assets 3.37 M
53.84 %22.36 %21.84 %Total Assets$577.7m
Current Liabilities 90.7 M
Accounts Payable 0
Short-Term Debt 1.16 M
Other Current Liabilities 89.5 M
Non-Current Liabilities 265 M
Long-Term Debt 253 M
Other Non-Current Liabilities 12.1 M
25.19 %71.08 %3.40 %Total Liabilities$355.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
ASSETS
Cash & Cash Equivalents 179.9 92.9 102.3 298.9 553.4 112.6 42.0 56.7 25.0 55.1 55.7 40.5 16.5 9.7 0.5 18 K 0.1 0.6 3.0 9.8 0.9 7.4 0.1 1.6 2.7 3.5 5.8 8.5 2.3
Short Term Investments 131.1 124.6 59.4 15.9 52.0 27.8 26.8 28.0 19.9 22.2 23.1 4.9 0 0 0 0 0 0 0 1.0 4.5 0.4 0 0 0 0 0 0 0
Receivables 129.2 51.1 0 1.4 0 0 95 K 0 83.9 K 0.2 85.5 K 27.2 K 0 0 0.2 0 0 0 0 0 0 0 0 0 0.2 0.3 0.4 0 0
Inventory 110.5 39.8 0 (23.6) 0 0 9.7 7.9 5.6 (16.0) 6.1 (3.2) 0 0 4.41 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 15.7 9.5 6.6 14.8 6.3 8.7 10.0 8.5 5.9 9.5 6.4 1.8 2.0 87.2 K 0.1 0.2 0.8 0.2 0.3 0.2 40.1 K 25 K 0.1 38.6 K 22.6 K 0 100 K 0 0
Total Current Assets 566.4 317.9 168.3 331.0 611.7 149.2 79.0 93.3 50.9 86.9 85.2 42.3 18.5 9.8 0.9 0.3 0.9 0.9 3.3 11.0 5.5 7.8 0.2 1.6 2.9 3.8 6.3 8.5 2.3
PP&E 7.2 8.1 10.8 11.1 11.8 11.8 2.5 2.7 2.4 47.1 K 20.4 K 5.72 K 1.16 K 0 2.98 K 3.54 K 9.07 K 44.5 K 83.7 K 0.1 0.1 8.02 K 55.9 K 0.1 0.2 100 K 0.3 0.3 100 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 2.8 5.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0.8 0 12.4 35.5 1.3 1.3 1.2 0.6 0.6 25.0 (22.8) 4.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 3.4 2.7 1.3 1.3 1.3 1.3 1.2 0.6 0.7 0.8 0.7 85.1 K (10.4) 438.0 17.8 98.4 K 0.4 70.5 K 70.5 K 70.5 K 70.5 K 0 19.9 K 22.8 K 70.2 K 100 K 100 K 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 577.7 329.6 193.6 379.6 625.6 163.0 83.6 97.4 54.8 113.5 86.7 48.1 22.1 15.9 18.6 0.4 1.2 1.0 3.4 11.2 5.6 7.8 0.3 1.8 3.2 4.0 6.5 8.8 2.4
LIABILITIES
Accounts Payable 0 38.5 42.0 0 37.0 30.0 36.4 25.9 15.3 9.3 4.0 4.8 1.1 0.7 0.2 0.2 0.5 1.3 1.4 1.6 1.1 0.5 0.2 0.5 0.8 0.5 0 0 0
Short Term Debt 1.2 1.4 3.2 3.8 23.8 1.6 67 K 0.1 68.9 K 0.2 0.3 0.7 0.7 0.9 2.1 1.3 70 K 0 0 0 0 0 0.8 0 0 0 0 0 0
Other Current Liabilities 78.1 13.8 8.0 61.5 26.7 52.8 2.3 1.8 1.4 0.8 56.5 0.7 26.1 61.9 K 1.0 1.0 0.9 0.6 0.6 48.3 K 52.1 K 0.4 (0.4) 0 0 0 0.7 0.4 0.3
Total Current Liabilities 90.7 53.7 53.2 65.4 87.6 84.4 38.9 28.0 16.9 10.5 5.1 6.3 2.2 1.6 3.3 2.5 1.5 1.9 1.9 1.7 1.2 1.0 0.6 0.5 2.1 0.5 0.7 0.4 0.3
Long Term Debt 252.6 109.3 81.5 76.6 18.1 39.2 0 0 0 0 0 64.5 K 2.5 3.3 16.1 0.4 1.2 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 (71.4) (67.2) 7.7 29.0 0 0 0 0 0 3.9 (2.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 12.1 0 0 0 0 0 19.8 1.4 0.8 0 0 0 0 0 4.6 4.2 2.9 0 0 0 0 0 0 0 0 100 K 100 K 0 0
Total Liabilities 355.3 169.1 135.0 142.5 106.3 124.4 59.6 97.4 54.8 113.5 86.7 48.1 6.5 6.3 24.0 7.2 5.6 1.9 1.9 1.7 1.2 1.0 0.6 0.5 2.1 0.6 0.6 0.4 0.3
EQUITY
Common Stock 0.2 0.2 0.1 0.1 0.1 0.1 84 K 73.2 K 56.8 K 54.1 K 45 K 34.3 K 25.8 K 0.3 0.1 70.6 K 70.6 K 70.6 K 60.1 K 60.1 K 28.3 K 23.4 K 17 K 16 K 6.12 K 0.5 0 0 0
Retained Earnings (1 529.2) (1 514.4) (1 527.0) (1 328.7) (980.6) (701.2) (528.3) (354.9) (236.4) (158.1) (95.2) (39.4) (18.9) (0.9) (61.3) (61.9) (59.3) (55.0) (43.0) (33.3) (14.0) (7.5) (28.3) (26.7) (24.8) (18.8) (16.3) (13.5) (8.4)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 0 6 6 6 0 0 35.8 K 32.4 K 26.8 K (0.2) (0.2) 987 0.3 7.76 K 77.1 K 218 218 (0.2) (0.3) (0.2) 100 K
Total Equity 222.4 160.5 (1 527.0) (1 328.7) 519.4 (701.2) 24.0 67.0 35.9 101.6 80.1 40.1 15.6 9.6 (5.4) (6.8) (4.4) (0.9) 1.5 9.5 4.5 6.8 (0.3) 1.2 1.1 3.4 5.9 8.4 2.1
Total Liabilities and Equity 577.7 329.6 (1 392.0) (1 186.2) 625.6 (576.8) 83.6 97.4 54.8 113.5 86.7 48.1 22.1 15.9 18.6 0.4 1.2 1.0 3.4 11.2 5.6 7.8 0.3 1.8 3.2 4.0 6.5 8.8 2.4
SHARES OUTSTANDING
Common Shares Outstanding 145.3 142.0 135.4 132.2 115.3 88.4 75.5 62.1 49.0 45.6 34.1 25.4 13.1 1.9 39.8 K 25.1 K 25.1 K 24.2 K 21.4 K 15.5 K 9.58 K 7.96 K 4.45 K 1.14 K 435 342 320 218 207